What we're seeing, particularly at Hoffmann-La Roche with our investment and our expansion of 200 jobs, is that there was some debate in the global family about whether Canada could bring some of that top talent. What we're seeing is that we're ahead in recruiting because of the talent that exists within the Canadian borders.
I would also add, though, that when you look around the world, some of the developing countries—the BRIC countries that we talk about—are also training, and their universities are ensuring that they have high levels of scientists coming out of their institutions as well. Therefore, while it's a very important factor in any investment, there are also developing countries that understand how important the talent pool is and are ensuring that they have the right number of individuals who are capable of moving science forward.